Marvel Biosciences MRVL Income Statements

*Across 3 years £2132.64 only £853.06

Hot Features

Connect with traders and investors in our Follow Feed community.

Explore comprehensive options data and use advanced filters with Options Flow.

Organize and monitor your stock and asset watchlist with Monitor.

Premium

Year End 31 July 2023	2019	2020	2021	2022	2023
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)
Total Revenue	0	0	0	0	0
Operating Income	-100k	0	-2.58M	-1.66M	-2.12M
Pre Tax Income	-98k	-10k	-3.04M	-2.55M	-2.29M
Net Income	-98k	-10k	-3.04M	-2.55M	-2.29M
Preferred Dividends	0	0	0	0	0
Basic Earnings Per Share (EPS)	-0.015	-0.001	-0.093	-0.069	-0.058
EBIT	-100k	0	-2.46M	-1.66M	-1.99M
EBITDA	-100k	0	-2.58M	-1.66M	-2.12M